{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 451552327
| IUPAC_name = (±)-1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one
| image = Pentylone.svg

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_CA = Schedule I
| legal_DE = Anlage I
| legal_UK = Class B
| legal_US = Schedule I
| legal_status = Illegal in Sweden
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 698963-77-8
| CAS_supplemental = <BR>17763-01-8 (hydrochloride)
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 60208608
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 29786041
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C13H17NO3/c1-3-4-10(14-2)13(15)9-5-6-11-12(7-9)17-8-16-11/h5-7,10,14H,3-4,8H2,1-2H3
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = DFMLULIEUUXXSA-UHFFFAOYSA-N

<!--Chemical data-->
| C=13 | H=17 | N=1 | O=3 
| molecular_weight = 235.278 g/mol
| smiles = c2cc1OCOc1cc2C(=O)C(NC)CCC
}}

'''β-Keto-Methylbenzodioxolylpentanamine''' ('''Pentylone''', '''βk-Methyl-K''', '''βk-MBDP''', '''methylenedioxypentedrone''') is a [[stimulant]] compound developed in the 1960s,<ref>Substituted phenyl-α-amino ketones. British Patent GB 1085135 (1969).</ref> which has been reported as a novel [[designer drug]] and identified in some samples of powders sold as "NRG-1", along with varying blends of other [[substituted cathinone]] derivatives including [[flephedrone]], [[3',4'-Methylenedioxy-α-pyrrolidinobutiophenone|MDPBP]], [[Methylenedioxypyrovalerone|MDPV]] and [[4'-Methyl-α-pyrrolidinopropiophenone|4-MePPP]]. 
It was also found in combination with 4-MePPP being sold as "NRG-3".<ref name="pmid21960541">{{cite journal |vauthors=Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J |title=Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones |journal=Drug Testing and Analysis |volume= 3|issue= 9|pages= 569–75|date=December 2010 |pmid=21960541 |doi=10.1002/dta.204 |url=}}</ref> Reports indicate side effects include feelings of paranoia, agitation and inability to sleep, with effects lasting for several days at high doses

==Pharmacology==

Pentylone acts as a [[serotonin-norepinephrine-dopamine reuptake inhibitor]] and a serotonin [[monoamine releasing agent|releasing agent]].<ref>{{Cite journal | doi = 10.1016/j.neuropharm.2013.11.008| pmid=24275046
 | url=http://www.sciencedirect.com/science/article/pii/S0028390813005327 | title = Monoamine transporter and receptor interaction profiles of a new series of designer cathinones| journal = Neuropharmacology| volume = 79| pages = 152–60| year = 2014| last1 = Simmler | first1 = L. D. | last2 = Rickli | first2 = A.| last3 = Hoener | first3 = M. C. | last4 = Liechti | first4 = M. E. }}</ref>

==Legality==

Pentylone is an [[Drugs controlled by the German Betäubungsmittelgesetz|Anlage I]] controlled substance in Germany.

It is also illegal in Sweden.<ref>{{cite web | url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2014/november/cannabinoider-foreslas-bli-klassade-som-halsofarlig-vara/ | title=Cannabinoider föreslås bli klassade som hälsofarlig vara  | language=Swedish | accessdate=29 June 2015}}</ref>

Pentylone is a [[Controlled Substances Act|Schedule I]] controlled drug in the US.<ref>[https://www.federalregister.gov/articles/2014/03/07/2014-04997/schedules-of-controlled-substances-temporary-placement-of-10-synthetic-cathinones-into-schedule-i Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I]</ref>

== See also ==
* [[Alpha-Pyrrolidinopentiophenone|α-PVP]]
* [[Methylenedioxypyrovalerone]] (MDPV)
* [[Methyl-K]]
* [[Pentedrone]]

== References ==
{{Reflist}}

{{Entactogens|state=extended}}
{{Stimulants}}
{{Serotonergics}}
{{Phenethylamines}}

[[Category:Cathinones]]
[[Category:Benzodioxoles]]
[[Category:Designer drugs]]
[[Category:Serotonin-norepinephrine-dopamine reuptake inhibitors]]
[[Category:Serotonin releasing agents]]
[[Category:Entactogens and empathogens]]


{{nervous-system-drug-stub}}